From: here@is.invalid   
      
   February 24, 2021   
   ...   
   ...   
   The string of studies with negative results disappoints Dr. Paul   
   Marik, who published those early dramatic claims. He's a critical care   
   specialist at Eastern Virginia Medical School.   
      
   "Some people think the matter is dead," he says. "We would disagree."   
      
   Marik says his own more recent experience is that the treatment is   
   only effective if given very early in the course of the disease. Marik   
   says he now gives the infusions when people first show up in the   
   emergency room, and doesn't wait for the hours or sometimes days it   
   takes before someone ends up in the intensive care unit. And that's   
   where researchers have studied this treatment.   
      
   "This should really be an emergency department study, not in ICU   
   study," he says. "Once you've waited until they get to the ICU you've   
   missed the boat."   
      
   Conducting research in the emergency department is a challenge because   
   it's tricky to explain a study and to get permission in the midst of a   
   health crisis. Marik says researchers in Belgium are trying to do   
   that, though, with the regime he developed (which is sometimes called   
   HAT therapy, based on the first letters of the technical names of its   
   components, hydrocortisone, ascorbic acid and thiamine).   
      
   In the meantime, doctors who have been using this treatment face a   
   decision. Should they keep offering it, given all these disappointing   
   results?   
      
      
   https://www.npr.org/sections/health-shots/2021/02/24/971000085/v   
   tamin-c-fails-again-as-treatment-for-sepsis   
      
   --- SoupGate-Win32 v1.05   
    * Origin: you cannot sedate... all the things you hate (1:229/2)